Mb. Stein et al., G-PROTEIN LEVEL QUANTIFICATION IN PLATELETS AND LEUKOCYTES FROM PATIENTS WITH PANIC DISORDER, Neuropsychopharmacology, 15(2), 1996, pp. 180-186
The objective of our study was to investigate if there ave abnormaliti
es in signal transducing G proteins in patients with panic disorder We
utilized selective antibodies to quantitate the levels of the G prote
in a subunits that regulate adenylyl cyclase activity (G alpha(s) and
G alpha(i2)) and phosphoinositide turnover (G alpha(q/11)) in platelet
membranes (and leukocyte membranes for G(alpha s)), and also carried
out pertussis toxin (PT) catalyzed [P-32]ADP-ribosylation in platelet
membranes from a group of 13 untreated panic disorder patients, 10 unt
reated social phobia patients, and 12 healthy subjects. There were no
significant differences among the three groups in the immunolabeling o
f G alpha(a) in platelets or leukocytes, or in the immunolabeling of G
alpha(i1/2), G(alpha/11), or PT-catalyzed [P-32]ADP-ribosylation in p
latelets. Within the constraints imposed by using peripheral blood cel
ls to reflect brain composition, our results do not provide support fo
r G protein abnormalities in patients with panic disorder. These resul
ts contrast with those obtained rising identical methodology in bipola
r affective disorder, where elevated G(alpha s) in leukocytes has been
reported (Manji et al. 1995).